Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Roos

Showing results (521-530 of 543) with videos related to

Pageof 55
Sort By:
Plos One|July 7, 2015
Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier GeneLeire Valcárcel-Ocete, Gorka Alkorta-Aranburu, Mikel Iriondo, et al.
EMBO Molecular Medicine|July 13, 2010
Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virusFrederik C Roos, Andrew M Roberts, Irene I L Hwang, et al.
Human Brain Mapping|November 22, 2011
Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophyRachael I Scahill, Nicola Z Hobbs, Miranda J Say, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 3, 2015
Maintenance tocolysis with nifedipine in threatened preterm labour: 2-year follow up of the offspring in the APOSTEL II trialEog van Vliet, L Seinen, C Roos, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|February 27, 2015
Reliability and factor structure of the Short Problem Behaviors Assessment for Huntington's disease (PBA-s) in the TRACK-HD and REGISTRY studiesJenny Callaghan, Cheryl Stopford, Natalie Arran, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 24, 2016
Nifedipine maintenance tocolysis and perinatal outcome: an individual participant data meta-analysisEog van Vliet, G H Dijkema, E Schuit, et al.
Gut|October 23, 2013
Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementationAd A van Bodegraven, Nathalie Bravenboer, Birgit I Witte, et al.
Haematologica|September 26, 2015
Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemiaMarissa A H den Hoed, Saskia M F Pluijm, Mariël L te Winkel, et al.
Neurology|November 12, 2010
Tapping linked to function and structure in premanifest and symptomatic Huntington diseaseN Bechtel, R I Scahill, H D Rosas, et al.
Human Pathology|August 20, 2018
High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinomaIris Polifka, Abbas Agaimy, Edwin Herrmann, et al.
Pageof 55

Showing results (521-530 of 543) with videos related to

Sort By:
Pageof 55
Plos One|July 7, 2015
Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier GeneLeire Valcárcel-Ocete, Gorka Alkorta-Aranburu, Mikel Iriondo, et al.
EMBO Molecular Medicine|July 13, 2010
Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virusFrederik C Roos, Andrew M Roberts, Irene I L Hwang, et al.
Human Brain Mapping|November 22, 2011
Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophyRachael I Scahill, Nicola Z Hobbs, Miranda J Say, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 3, 2015
Maintenance tocolysis with nifedipine in threatened preterm labour: 2-year follow up of the offspring in the APOSTEL II trialEog van Vliet, L Seinen, C Roos, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|February 27, 2015
Reliability and factor structure of the Short Problem Behaviors Assessment for Huntington's disease (PBA-s) in the TRACK-HD and REGISTRY studiesJenny Callaghan, Cheryl Stopford, Natalie Arran, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 24, 2016
Nifedipine maintenance tocolysis and perinatal outcome: an individual participant data meta-analysisEog van Vliet, G H Dijkema, E Schuit, et al.
Gut|October 23, 2013
Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementationAd A van Bodegraven, Nathalie Bravenboer, Birgit I Witte, et al.
Haematologica|September 26, 2015
Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemiaMarissa A H den Hoed, Saskia M F Pluijm, Mariël L te Winkel, et al.
Neurology|November 12, 2010
Tapping linked to function and structure in premanifest and symptomatic Huntington diseaseN Bechtel, R I Scahill, H D Rosas, et al.
Human Pathology|August 20, 2018
High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinomaIris Polifka, Abbas Agaimy, Edwin Herrmann, et al.
Pageof 55